CIK 0001410098 · Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-23 | Todisco Joseph Chief Executive Officer | Grant or award | +225,900 | 724,899 | ||
| 2026-01-23 | Todisco Joseph Chief Executive Officer | Shares withheld for taxes | −27,306 | $7.27 | $199K | 697,593 |
| 2026-01-21 | Dillione Janet Director | Sale 10b5-1 | −10,000 | $6.88 | $69K | 38,473 |
| 2026-01-17 | Todisco Joseph Chief Executive Officer | Shares withheld for taxes | −22,665 | $6.78 | $154K | 498,999 |
| 2026-01-16 | Todisco Joseph Chief Executive Officer | Option exercise | +29,585 | $3.38 | $100K | 521,664 |
| 2026-01-16 | Todisco Joseph Chief Executive Officer | Option exercise · Stock Option (Right to Buy Common Stock) | −29,585 | 411,245 | ||
| 2026-01-12 | Hurlburt Elizabeth Chief Operating Officer | Shares withheld for taxes | −5,794 | $7.15 | $41K | 160,301 |
| 2026-01-12 | Todisco Joseph Chief Executive Officer | Shares withheld for taxes | −17,417 | $7.15 | $125K | 492,079 |
| 2026-01-12 | Lefkowitz Steven W Director | Option exercise | +15,000 | $5.63 | $84K | 95,498 |
| 2026-01-12 | Lefkowitz Steven W Director | Option exercise · Stock Option (Right to Buy Common Stock) | −15,000 | 0 | ||
| 2026-01-08 | Seckler Michael David Chief Commercial Officer | Grant or award | +133,156 | 133,156 | ||
| 2026-01-02 | Hurlburt Elizabeth Chief Operating Officer | Shares withheld for taxes | −10,895 | $12.16 | $132K | 166,095 |
| 2026-01-02 | Zelnick Kaufman Beth Chief Legal Officer | Shares withheld for taxes | −11,333 | $12.16 | $138K | 169,085 |
| 2025-12-30 | DUNTON ALAN W Director | Option exercise 10b5-1 | +20,000 | $4.03 | $81K | 60,250 |
| 2025-12-30 | DUNTON ALAN W Director | Sale 10b5-1 | −20,000 | $13.00 | $260K | 40,250 |
| 2025-12-30 | DUNTON ALAN W Director | Option exercise · Stock Option (Right to Buy Common Stock) 10b5-1 | −20,000 | 0 | ||
| 2025-12-18 | Todisco Joseph Chief Executive Officer | Option exercise 10b5-1 | +30,000 | $4.43 | $133K | 539,496 |
| 2025-12-18 | Todisco Joseph Chief Executive Officer | Sale 10b5-1 | −30,000 | $12.00 | $360K | 509,496 |
| 2025-12-18 | Todisco Joseph Chief Executive Officer | Option exercise · Stock Option (Right to Buy Common Stock) 10b5-1 | −30,000 | 370,000 | ||
| 2025-12-09 | Dillione Janet Director | Option exercise 10b5-1 | +19,000 | $9.55 | $181K | 67,473 |
Page 2 of 9 · 176 trades